Purpose: The 2-[F-18]-Fluoro-2-deoxy-D-glucose (FDG) uptake in positron emission tomography (PET) and serum neutrophil/lymphocyte ratio (NLR) are recently noteworthy prognostic factors. We studied the prognostic factor to predict early recurrence after curative resection for pulmonary adenocarcinoma including FDG uptake and NLR. Methods: We performed a retrospective review of 23 patients who underwent a complete resection for pulmonary adenocarcinoma. The patients were divided into 2 groups: 19 patients in the disease-free group, and 4 patients in the recurrent group. Clinical and pathological factors concerning the recurrence within 1 year of surgery were analyzed between two groups. Results: No significant differences between the recurrent group and disease-free group was seen in age, gender, CEA, NLR, CRP, pathological stage, pleural invasion, pathological grading, Ki-67 expression, venous invasion and lymphatic invasion. The SUVmax was significantly elevated in the recurrent group (12.5 ± 2.01 vs. 5.70 ± 3.97, p = 0.0094). Tumor size was significantly larger in the recurrent group (5.58 ± 0.71 vs. 3.62 ± 1.33 cm, p = 0.0058). The first, recurrent sites in 4 patients were brain, in 3 patients; and lung, in 1 patient. Conclusion: Both tumor size and SUVmax are possible predictors of early recurrence after curative resection in patients with pulmonary adenocarcinoma. Although it is impossible to determine the SUVmax as an independent prognostic factor, the SUVmax may be one of the predictors of early hematogenous recurrence in surgically treated pulmonary adenocarcinoma.
Introduction
The tumor-node-metastasis (TNM) staging system is the most important tool used by clinical oncologists to estimate prognosis and to choose the best combination of treatment modalities. [1] [2] The clinical or pathological TNM staging does not always provide a satisfactory explanation for differences in relapse and survival. [2] [3] Therefore, it is important to predict relapses and to prevent with an active chemotherapy or radiation after curative surgery. [2] [3] 2-[F-18]-Fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) is a functional imaging technique that permits characterization of tumor metabolism. FDG PET has played an important role in the staging of various malignant tumors including non-small cell lung cancer (NSCLC).
3) It is expected that FDG-PET can also provide prognostic information on NSCLC patients, since FDG uptake should reflect the aggressiveness of cancer cells. 3) Inflammatory cells in the tumor microenvironment have significant effects on tumor development. 4) A highneutrophil-lymphocyte ration (NLR) may be related poor prognosis in patients with colorectal cancer and advanced gastric cancer. [4] [5] Recently, an increasing neutrophil counts or NLR have been reported as an independent prognostic factor in patients with NSCLC. [4] [5] [6] In this study, we retrospectively reviewed 23 patients with pulmonary adenocarcinoma, all of whom were treated with surgery. The prognostic value of clinical or pathological factors including FDG-PET and NLR were analyzed.
Patients and Methods
In our hospital PET was introduced in July 2008. Since July 2008, chest computed tomography (CT) and brain magnetic resonance imaging (MRI), in addition to either bone scintigraphy or FDG-PET/CT has been performed as a preoperative evaluation for patients with lung cancer in our division. A total of 23 patients, who underwent complete resection for pulmonary adenocarcinoma between July 2008 and November 2009 after evaluation with FDG-PET/CT in our hospital, were included in the present study. Patients, who underwent bone scintigraphy in another hospital as a preoperative evaluation, were excluded in this study. The duration of observation was 14.6 ± 3.11 months. The patients (14 men and 9 women) were 47 to 78 years old (mean, 65 years). These patients were divided into two groups: 19 patients in the diseasefree group and 4 patients in the recurrent group. The recurrent group included patients who experienced recurrence within a year of their initial surgery.
Parameters used for analysis of prognosis were pathological stage, preoperative serum CEA, C-reactive protein, tumor size, histological grading, pleural invasion, venous invasion, lymphatic invasion and Ki-67 expression. NLR and the maximum standardized uptake value (SUVmax) of tumor in PET-CT were also evaluated. Stage of lung cancer was shown according to the 6th edition of the general rule for clinical and pathological records of lung cancer of the Japan Lung Cancer Society.
Mann-Whitney U test and the Chi-squared test looked for differences between the two groups. P values less than 0.05 were considered statistically significant.
Results
Pathological stage and the results of preoperative clinical factors of the two groups are shown in Table 1 . The disease-free group consisted of 19 patients with a mean age of 66.5 years. Four patients had stage IA (21.0%); 12 patients, IB (63.1%); 1 patient, IIB (5.3%); 1 patient, IIIA (5.3%); and 1 patient, IIIB (5.3%). The recurrent group consisted of 4 patients with a mean age of 62.5 years. Two patients had stage IB (50.0%), and 2 had IIB (50.0%). No significant differences in T-factor, N-factor, CEA, white blood cell count, NLR, and CRP were seen between two groups. However, SUVmax was significantly elevated in the recurrent group compared to the disease-free group (12.5 ± 2.01 vs. 5.70 ± 3.97, p = 0.0094). The SUVmax of all 4 patients in the recurrent group was more than 10.
Tumor size was significantly larger in the recurrent group compared to the disease-free group (5.58 ± 0.71 vs. 3.62 ± 1.33, p = 0.0058, Table 2 ). No significant difference was seen in histological grading, pleural invasion, venous invasion, lymphatic invasion and Ki-67 expression between two groups. Histologically, type A or B of Noguchi classification was included in neither diseasefree group nor recurrent group.
Significant positive correlation was seen tumor size and the SUVmax by Spearman's correlation (r = 0.482, p = 0.005).
As for the clinical findings of 4 patients in recurrent group, the most frequent first recurrence site was brain in 3 patients (75.0%) and lung in 1 patient (25.0%), and it was considered to occur by a hemotogeneous pathway. Adjuvant chemotherapy was performed in 3 patients (75.0%), and these three patients were treated with an oral administration of tegaful / urasil before the recurrence. Postoperative elevation of serum CEA was seen in 3 patients (75.0%) before the image diagnosis. However, the postoperative elevation of NLR was seen in 3 patients (75.0%) after the image diagnosis.
Discussion
NSCLC is a heterogeneous disease including several histological subtypes with different biological behavior and clinical aggressiveness. 7) Therefore, more accurate and widely adoptable biologic markers are needed to identify patients with surgically resected NSCLC who could benefit from adjuvant chemotherapy. SUVmax on FDG-PET examination and NLR are recently noteworthy prognostic markers in NSCLC.
The usefulness of SUVmax on FDG-PET as a prognostic factor in NSCLC has been reported, and the optimal cut-off values for prognosis were considered 3.5 to 6.7.
2, 3, 7) Casali et al reported 7) that the SUVmax related to histological subtypes, histological grading and pathologic stage. In addition, the optimal cut-off values of SUVmax to predict prognosis were reported 5 for adenocarcinoma 7) and 10 for other non-adenocarcinoma NSCLC subtypes. 7) In the present study, the SUVmax of the tumor was significantly elevated in patients who experienced recurrence within 1 year of complete resection for adenocarcinoma, and the SUVmax was more than 10 in 75% of recurrent patients. Therefore, there is a possibility that 10 is the optimal cut-off values of the SUVmax for prognosis in pulmonary adenocarcinoma.
The FDG uptake in NSCLC has been correlated with tumor growth rate and proliferation capacity.
2) The FDG uptake in NSCLC has also been correlated with aggressiveness (pleural invasion, vascular invasion, and lymphatic permeation), as determined by the pathology of adenocarcinoma in lung. [2] [3] [4] [5] [6] [7] [8] Aggressiveness, especially vascular invasion, is an important determinant of recurrence in stage I NSCLC. 2, 9, 10) In our present study, the primary recurrent organs in the four patients with relapse within 1 year of surgery were brain and lung, and hematogenous pathway was suspected.
Although it is impossible to determine SUVmax as an independent prognostic factor in patients with pulmonary adenocarcinoma because the correlation between SUVmax and tumor size is seen, SUVmax may be a useful predictor of early hematogenous recurrence after curative resection in patients with pulmonary adenocarcinoma. However, additional studies including a larger number of patients in these groups should be conducted.
The NLR, an inexpensive, reproducible, and widely available blood test, has been found to be an important indicator of adverse prognosis in colorectal and gastric cancer.
5) Sarraf et al. 5) reported that increasing NLR on preoperative blood tests were associated with higher stage but remained an independent predictor of survival after complete resection for NSCLC. The preoperative NLR reflects inflammation status, and increases number of neutrophils and/or decreased number of lymphocytes may suppress lymphokine-activated killer cells, thereby increasing the propensity of metastasis. 11) Although the prognostic significance of the preoperative NLR was not found in patients with pulmonary adenocarcinoma, further examination should be followed.
Conclusion
The positive correlation between tumor size and SUVmax of the pulmonary lesion was seen in patients with pulmonary adenocarcinoma. Both tumor size and the SUVmax have possibility as a predictor of early recurrence after curative resection in patients with pulmonary adenocarcinoma. Although it is impossible to determine the SUVmax as an independent prognostic factor, the SUVmax may be one of the predictors of early hematogenous recurrence in surgically treated pulmonary adenocarcinoma. Further examination should be followed to consider the SUVmax as an independent prognostic factor and to determine the optimal cut-off values.
